Results 221 to 230 of about 15,925,070 (360)
B‐cell chronic lymphocytic leukemia (B‐CLL) and monoclonal B‐cell lymphocytosis (MBL) show altered proteomes and phosphoproteomes, analyzed using mass spectrometry, protein microarrays, and western blotting. Identifying 2970 proteins and 316 phosphoproteins, including 55 novel phosphopeptides, we reveal BCR and NF‐kβ/STAT3 signaling in disease ...
Paula Díez+17 more
wiley +1 more source
Regioselective rapid ene-type reaction (RRER) enables bioconjugation of histone serotonylation. [PDF]
Wu J+5 more
europepmc +1 more source
Creatine metabolism: energy homeostasis, immunity and cancer biology
L. Kazak, P. Cohen
semanticscholar +1 more source
Ubiquitination of transcription factors in cancer: unveiling therapeutic potential
In cancer, dysregulated ubiquitination of transcription factors contributes to the uncontrolled growth and survival characteristics of tumors. Tumor suppressors are degraded by aberrant ubiquitination, or oncogenic transcription factors gain stability through ubiquitination, thereby promoting tumorigenesis.
Dongha Kim, Hye Jin Nam, Sung Hee Baek
wiley +1 more source
Analysis of disease resistance of ZmERS4 -overexpressing rice. [PDF]
Huang W, Ning J, Su B, Liu W, Ding T.
europepmc +1 more source
On a new type of catastrophist representation for modelisation in biology and cognitive sciences
Philippe Lacorre
openalex +1 more source
A biology-driven deep generative model for cell-type annotation in cytometry
Quentin Blampey+6 more
openalex +2 more sources
Targeted protein degradation in oncology: novel therapeutic opportunity for solid tumours?
Current anticancer therapies are limited by the occurrence of resistance and undruggability of most proteins. Targeted protein degraders are novel, promising agents that trigger the selective degradation of previously undruggable proteins through the recruitment of the ubiquitin–proteasome machinery. Their mechanism of action raises exciting challenges,
Noé Herbel, Sophie Postel‐Vinay
wiley +1 more source